SK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough Medicines
September 19, 2023 FOR IMMEDIATE RELEASE – CBM brings extensive cell and gene therapy expertise to SK pharmteco portfolio and
September 19, 2023 FOR IMMEDIATE RELEASE – CBM brings extensive cell and gene therapy expertise to SK pharmteco portfolio and
An open letter from our CEO, Joerg Ahlgrimm to SK pharmteco Customers SK pharmteco’s mission is to improve patient outcomes
RANCHO CORDOVA, CA – January 9, 2023 – SK pharmteco, a global contract development and manufacturing organization serving the pharmaceutical
"*" indicates required fields